ProQR Therapeutics NV (PRQR)
1.625
-0.02
(-1.52%)
USD |
NASDAQ |
Oct 07, 12:38
ProQR Therapeutics PE Ratio
PE Ratio Chart
Historical PE Ratio Data
| Date | Value |
|---|---|
| October 07, 2026 |
PE Ratio Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
PE Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
PE Ratio Benchmarks
| Pharming Group NV | 77.88 |
| NewAmsterdam Pharma Co. NV | -- |
| argenx SE | 35.61 |
| Mirum Pharmaceuticals, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 8.859 |
PE Ratio Related Metrics
| PS Ratio | 8.048 |
| PEG Ratio | -0.7654 |
| Price to Book Value | 2.524 |
| Price | 1.625 |
| Earnings Yield | -28.54% |
| Market Cap | 229.32M |
| PEGY Ratio | -0.7654 |